PYRIDINE COMPOUNDS AS KV7.2 ENHANCERS

The invention provides new heterocyclic compounds having the general formula (I), or a solvate or a pharmaceutically acceptable salt thereof:wherein R1, R2, R3, R4, R5, R6 and n are as defined herein, compositions including the compounds, processes of manufacturing the compounds and methods of using...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DAVIES, Nicholas Gareth Morse, MOWREY, David, MECHIN, Ingrid, REDONDO PENA, Roger Lluis, NAGARAJAN, Karthigeyan, NAIR, Anil, NORCROSS, Roger David, CHAPMAN, Mark, SMRCINA, Martin, LEBRETON, Sylvain, SAFAROVA, Alena, GERLACH, Aaron
Format: Patent
Sprache:eng ; fre ; ger
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator DAVIES, Nicholas Gareth Morse
MOWREY, David
MECHIN, Ingrid
REDONDO PENA, Roger Lluis
NAGARAJAN, Karthigeyan
NAIR, Anil
NORCROSS, Roger David
CHAPMAN, Mark
SMRCINA, Martin
LEBRETON, Sylvain
SAFAROVA, Alena
GERLACH, Aaron
description The invention provides new heterocyclic compounds having the general formula (I), or a solvate or a pharmaceutically acceptable salt thereof:wherein R1, R2, R3, R4, R5, R6 and n are as defined herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP4433472A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP4433472A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP4433472A13</originalsourceid><addsrcrecordid>eNrjZFANiAzydPH0c1Vw9vcN8A_1cwlWcAxW8A4z1zNScPXzcPRzdg0K5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJibGxibmRo6GxkQoAQBJ8SKp</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>PYRIDINE COMPOUNDS AS KV7.2 ENHANCERS</title><source>esp@cenet</source><creator>DAVIES, Nicholas Gareth Morse ; MOWREY, David ; MECHIN, Ingrid ; REDONDO PENA, Roger Lluis ; NAGARAJAN, Karthigeyan ; NAIR, Anil ; NORCROSS, Roger David ; CHAPMAN, Mark ; SMRCINA, Martin ; LEBRETON, Sylvain ; SAFAROVA, Alena ; GERLACH, Aaron</creator><creatorcontrib>DAVIES, Nicholas Gareth Morse ; MOWREY, David ; MECHIN, Ingrid ; REDONDO PENA, Roger Lluis ; NAGARAJAN, Karthigeyan ; NAIR, Anil ; NORCROSS, Roger David ; CHAPMAN, Mark ; SMRCINA, Martin ; LEBRETON, Sylvain ; SAFAROVA, Alena ; GERLACH, Aaron</creatorcontrib><description>The invention provides new heterocyclic compounds having the general formula (I), or a solvate or a pharmaceutically acceptable salt thereof:wherein R1, R2, R3, R4, R5, R6 and n are as defined herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240925&amp;DB=EPODOC&amp;CC=EP&amp;NR=4433472A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20240925&amp;DB=EPODOC&amp;CC=EP&amp;NR=4433472A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DAVIES, Nicholas Gareth Morse</creatorcontrib><creatorcontrib>MOWREY, David</creatorcontrib><creatorcontrib>MECHIN, Ingrid</creatorcontrib><creatorcontrib>REDONDO PENA, Roger Lluis</creatorcontrib><creatorcontrib>NAGARAJAN, Karthigeyan</creatorcontrib><creatorcontrib>NAIR, Anil</creatorcontrib><creatorcontrib>NORCROSS, Roger David</creatorcontrib><creatorcontrib>CHAPMAN, Mark</creatorcontrib><creatorcontrib>SMRCINA, Martin</creatorcontrib><creatorcontrib>LEBRETON, Sylvain</creatorcontrib><creatorcontrib>SAFAROVA, Alena</creatorcontrib><creatorcontrib>GERLACH, Aaron</creatorcontrib><title>PYRIDINE COMPOUNDS AS KV7.2 ENHANCERS</title><description>The invention provides new heterocyclic compounds having the general formula (I), or a solvate or a pharmaceutically acceptable salt thereof:wherein R1, R2, R3, R4, R5, R6 and n are as defined herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFANiAzydPH0c1Vw9vcN8A_1cwlWcAxW8A4z1zNScPXzcPRzdg0K5mFgTUvMKU7lhdLcDApuriHOHrqpBfnxqcUFicmpeakl8a4BJibGxibmRo6GxkQoAQBJ8SKp</recordid><startdate>20240925</startdate><enddate>20240925</enddate><creator>DAVIES, Nicholas Gareth Morse</creator><creator>MOWREY, David</creator><creator>MECHIN, Ingrid</creator><creator>REDONDO PENA, Roger Lluis</creator><creator>NAGARAJAN, Karthigeyan</creator><creator>NAIR, Anil</creator><creator>NORCROSS, Roger David</creator><creator>CHAPMAN, Mark</creator><creator>SMRCINA, Martin</creator><creator>LEBRETON, Sylvain</creator><creator>SAFAROVA, Alena</creator><creator>GERLACH, Aaron</creator><scope>EVB</scope></search><sort><creationdate>20240925</creationdate><title>PYRIDINE COMPOUNDS AS KV7.2 ENHANCERS</title><author>DAVIES, Nicholas Gareth Morse ; MOWREY, David ; MECHIN, Ingrid ; REDONDO PENA, Roger Lluis ; NAGARAJAN, Karthigeyan ; NAIR, Anil ; NORCROSS, Roger David ; CHAPMAN, Mark ; SMRCINA, Martin ; LEBRETON, Sylvain ; SAFAROVA, Alena ; GERLACH, Aaron</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP4433472A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DAVIES, Nicholas Gareth Morse</creatorcontrib><creatorcontrib>MOWREY, David</creatorcontrib><creatorcontrib>MECHIN, Ingrid</creatorcontrib><creatorcontrib>REDONDO PENA, Roger Lluis</creatorcontrib><creatorcontrib>NAGARAJAN, Karthigeyan</creatorcontrib><creatorcontrib>NAIR, Anil</creatorcontrib><creatorcontrib>NORCROSS, Roger David</creatorcontrib><creatorcontrib>CHAPMAN, Mark</creatorcontrib><creatorcontrib>SMRCINA, Martin</creatorcontrib><creatorcontrib>LEBRETON, Sylvain</creatorcontrib><creatorcontrib>SAFAROVA, Alena</creatorcontrib><creatorcontrib>GERLACH, Aaron</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DAVIES, Nicholas Gareth Morse</au><au>MOWREY, David</au><au>MECHIN, Ingrid</au><au>REDONDO PENA, Roger Lluis</au><au>NAGARAJAN, Karthigeyan</au><au>NAIR, Anil</au><au>NORCROSS, Roger David</au><au>CHAPMAN, Mark</au><au>SMRCINA, Martin</au><au>LEBRETON, Sylvain</au><au>SAFAROVA, Alena</au><au>GERLACH, Aaron</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>PYRIDINE COMPOUNDS AS KV7.2 ENHANCERS</title><date>2024-09-25</date><risdate>2024</risdate><abstract>The invention provides new heterocyclic compounds having the general formula (I), or a solvate or a pharmaceutically acceptable salt thereof:wherein R1, R2, R3, R4, R5, R6 and n are as defined herein, compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; fre ; ger
recordid cdi_epo_espacenet_EP4433472A1
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title PYRIDINE COMPOUNDS AS KV7.2 ENHANCERS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T17%3A18%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DAVIES,%20Nicholas%20Gareth%20Morse&rft.date=2024-09-25&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP4433472A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true